PMID- 24029241 OWN - NLM STAT- MEDLINE DCOM- 20140108 LR - 20131021 IS - 1945-7170 (Electronic) IS - 0013-7227 (Linking) VI - 154 IP - 11 DP - 2013 Nov TI - Effects of antenatal synthetic glucocorticoid on glucocorticoid receptor binding, DNA methylation, and genome-wide mRNA levels in the fetal male hippocampus. PG - 4170-81 LID - 10.1210/en.2013-1484 [doi] AB - The endogenous glucocorticoid (GC) surge in late gestation plays a vital role in maturation of several organ systems. For this reason, pregnant women at risk of preterm labor are administered synthetic glucocorticoids (sGCs) to promote fetal lung development. Animal studies have shown that fetal sGC exposure can cause life-long changes in endocrine and metabolic function. We have previously shown that antenatal sGC treatment is associated with alterations in global DNA methylation and modifications to the hippocampal methylome and acetylome. In this study, we hypothesized that: 1) there are changes in the transcriptional landscape of the fetal hippocampus in late gestation, associated with the endogenous cortisol surge; 2) fetal sGC exposure alters genome-wide transcription in the hippocampus; and 3) these changes in transcription are associated with modified glucocorticoid receptor (GR) DNA binding and DNA methylation. sGC was administered as 2 courses on gestational days (GD) 40, 41, 50, and 51, and the hippocampi of fetal guinea pigs were examined before (GD52) and after (GD65) the endogenous cortisol surge (Term approximately GD67). We also analyzed fetal hippocampi 24 hours and 14 days following maternal sGC injections (n = 3-4/group). Genome-wide modification of transcription and GR DNA binding occurred in late gestation, in parallel with the normal GC surge. Further, sGC exposure had a substantial impact on the hippocampal transcriptome, GR-DNA binding, and DNA methylation at 24 hours and 14 days following the final sGC treatment. These data support the hypothesis that GC exposure in late gestation plays a significant role in modifying the transcriptional and epigenetic landscape of the developing fetal hippocampus and that substantial effects are evident for at least 2 weeks after sGC exposure. FAU - Crudo, Ariann AU - Crudo A AD - Faculty of Medicine, University of Toronto, 1 King's College Circle, Toronto, Ontario, Canada M5S 1A8. Stephen.Matthews@utoronto.ca. FAU - Petropoulos, Sophie AU - Petropoulos S FAU - Suderman, Matthew AU - Suderman M FAU - Moisiadis, Vasilis G AU - Moisiadis VG FAU - Kostaki, Alisa AU - Kostaki A FAU - Hallett, Michael AU - Hallett M FAU - Szyf, Moshe AU - Szyf M FAU - Matthews, Stephen G AU - Matthews SG LA - eng GR - MOP-126166/Canadian Institutes of Health Research/Canada PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130912 PL - United States TA - Endocrinology JT - Endocrinology JID - 0375040 RN - 0 (Glucocorticoids) RN - 0 (RNA, Messenger) RN - 0 (Receptors, Glucocorticoid) RN - 9842X06Q6M (Betamethasone) SB - IM MH - Animals MH - Betamethasone/administration & dosage/*pharmacology MH - *DNA Methylation MH - Female MH - Fetal Development/physiology MH - Gene Expression Regulation, Developmental/drug effects/physiology MH - Genome MH - Glucocorticoids/administration & dosage/pharmacology MH - Guinea Pigs MH - Hippocampus/embryology/*metabolism MH - Male MH - Pregnancy MH - *Protein Binding MH - RNA, Messenger/genetics/*metabolism MH - Receptors, Glucocorticoid/genetics/*metabolism MH - Transcriptome EDAT- 2013/09/14 06:00 MHDA- 2014/01/09 06:00 CRDT- 2013/09/14 06:00 PHST- 2013/09/14 06:00 [entrez] PHST- 2013/09/14 06:00 [pubmed] PHST- 2014/01/09 06:00 [medline] AID - en.2013-1484 [pii] AID - 10.1210/en.2013-1484 [doi] PST - ppublish SO - Endocrinology. 2013 Nov;154(11):4170-81. doi: 10.1210/en.2013-1484. Epub 2013 Sep 12.